multiple flags

US COVID-19 deaths top the 200,000 mark

Deaths outpace an earlier projection, more upheaval keep the US response unsteady, and new developments add clarity to vaccine expectations.

Patient with tracheostomy and ventilator

As US COVID-19 deaths near 200,000, CDC reverses itself again

The CDC again waffles on guidance, this time regarding the mode of virus spread.

Mask-wearing tourish coughing in airport

Studies trace COVID-19 spread to international flights

One involves a symptomatic passenger who likely infected at least 12 others.

Vaccine vials

Support grows for global vaccine plan as pandemic tops 31 million

India, with 5.5 million cases, is closing in on the US, which has 6.8 million.


University of Minnesota, Mayo building aerial view

Aug 7, 2020
New York Times editorial 
on the need of another restrictive lockdown to saves lives and the economy, by Director Michael Osterholm, PhD, MPH, and Neel Kashkari, MBA, President of the Federal Reserve Bank of Minneapolis.

Apr 28, 2020
New York Times editorial 
on the status of COVID-19 testing and shortcomings, by Director Michael Osterholm, PhD, MPH, and Mark Olshaker.

Apr 19, 2020
Centers of Excellence for Influenza Research and Surveillance (CEIRS) CIDRAP staff developed an Influenza Response Plan to improve science preparedness for the CEIRS networks.

Mar 27, 2020
New York Times editorial on stating a number of hard truths about our current situation and how national leadership is crucial in these times, by Director Michael Osterholm, PhD, MPH, and Mark Olshaker. 

More Inside CIDRAP


Sep 22, 2020
  • Eastern equine encephalitis in Massachusetts
  • Flu vaccine priority during COVID-19
Sep 21, 2020
  • COVID-19 and stress, depression
  • Incentives for antibiotic development
  • New DRC Ebola case
  • More avian flu in poultry

Stewardship / Resistance Scan

Sep 22, 2020
  • CARB-X funds for UTI drug
  • Impact of antibiotic guidelines in Japan


Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

The Osterholm Quote

"If a vaccine was developed that is 50 percent effective in preventing Covid, it would still be licensed. Of course, we'd like a higher degree of effectiveness, but as with the flu vaccine, 50 percent protection is better than zero. A Covid vaccine probably won't be nearly as effective as the childhood vaccines we're familiar with."